NCT06109662View on ClinicalTrials.gov

Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease

Active, not recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 12, 2024

Primary Completion Date

November 2, 2025

Study Completion Date

November 2, 2025

Conditions
Chronic Kidney DiseasesSarcopenia
Interventions
DIAGNOSTIC_TEST

Cystatin C eGFR

Cystatin C eGFR is not used routinely currently in clinical practice in the UK. It involved a blood test to analyse Cystatin C.

OTHER

Bioimpedance Analysis (Body composition analysis)

Participants will stand on a bioimpedance analysis machine which will measure different components of body composition

Trial Locations (1)

Unknown

University Hospitals of Derby and Burton NHS Foundation Trust, Derby

All Listed Sponsors
lead

University Hospitals of Derby and Burton NHS Foundation Trust

OTHER

NCT06109662 - Multimorbidity and Sarcopenia Feasibility Study in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter